Home lifeDomestic services apparel Entertainment News Player community More

Elliott Statement on Aspen Technology, Inc.

2025-02-10 IDOPRESS

WEST PALM BEACH,Fla.,Feb. 7,2025 -- Elliott Investment Management L.P. ("Elliott"),which manages funds that together have an investment of more than $1.5 billion in Aspen Technology,Inc. (NASDAQ: AZPN) (the "Company" or "AspenTech"),today issued the following statement regarding the Company's recently announced agreement with Emerson Electric Co. (NYSE: EMR) ("Emerson"):

"As the largest minority investor in AspenTech,we disagree with the Company's decision to support a $265.00 per share tender offer by its majority stockholder,Emerson,to acquire the AspenTech shares it does not already own. Emerson's offer is highly opportunistic and substantially undervalues the Company. Elliott has no intention of tendering its shares at the current price."

About Elliott

Elliott Investment Management L.P. (together with its affiliates,"Elliott") manages approximately$69.7 billionof assets as ofJune 30,2024. Founded in 1977,it is one of the oldest funds under continuous management. The Elliott funds' investors include pension plans,sovereign wealth funds,endowments,foundations,funds-of-funds,high net worth individuals and families,and employees of the firm.

Media Contact


Alice Best


Elliott Advisors (UK) Limited


T: +44 203 009 1715


abest@elliottadvisors.co.uk

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share

Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion

LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025

2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing

©copyright2009-2020New York Fashion News    Contact Us  SiteMap